Format
Sort by
Items per page

Send to

Choose Destination

Best matches for quetiapine AND ("QT" OR Torsad*):

Quetiapine and the need for a thorough QT/QTc study. Hasnain M et al. J Clin Psychopharmacol. (2014)

Management of psychosis and agitation in medical-surgical patients who have or are at risk for prolonged QT interval. Ries R et al. J Psychiatr Pract. (2014)

Quetiapine (Seroquel) and QT-interval prolongation. et al. Med Lett Drugs Ther. (2011)

Search results

Items: 1 to 20 of 116

1.

Abnormal serum potassium levels and 6-month all-cause mortality in patients co-treated with antipsychotic and diuretic drugs - A Danish register-based cohort study.

Marcussen M, Polcwiartek C, Mills EHA, Jirback F, Bylin P, Torp-Pedersen C, Søgaard P, Kragholm K.

Eur Neuropsychopharmacol. 2018 Sep;28(9):1006-1014. doi: 10.1016/j.euroneuro.2018.06.008. Epub 2018 Jul 17.

PMID:
30017260
2.

Effects of atypical antipsychotic drugs on QT interval in patients with mental disorders.

Aronow WS, Shamliyan TA.

Ann Transl Med. 2018 Apr;6(8):147. doi: 10.21037/atm.2018.03.17.

3.

Psychotropic Pharmacotherapy Associated With QT Prolongation Among Veterans With Posttraumatic Stress Disorder.

Stock EM, Zeber JE, McNeal CJ, Banchs JE, Copeland LA.

Ann Pharmacother. 2018 Sep;52(9):838-848. doi: 10.1177/1060028018769425. Epub 2018 Apr 11.

PMID:
29642718
4.

Distribution of Eight QT-Prolonging Drugs and Their Main Metabolites Between Postmortem Cardiac Tissue and Blood Reveals Potential Pitfalls in Toxicological Interpretation.

Mikkelsen CR, Jornil JR, Andersen LV, Banner J, Hasselstrøm JB.

J Anal Toxicol. 2018 Jul 1;42(6):375-383. doi: 10.1093/jat/bky018.

PMID:
29579279
5.

QTc prolongation in short-term treatment of schizophrenia patients: effects of different antipsychotics and genetic factors.

Spellmann I, Reinhard MA, Veverka D, Zill P, Obermeier M, Dehning S, Schennach R, Müller N, Möller HJ, Riedel M, Musil R.

Eur Arch Psychiatry Clin Neurosci. 2018 Jun;268(4):383-390. doi: 10.1007/s00406-018-0880-8. Epub 2018 Feb 10.

PMID:
29429138
6.

Probable Acquired QTc Prolongation and Subsequent Torsades de Pointes Attributable to Quetiapine.

Giancaterino S, Solimine S.

Prim Care Companion CNS Disord. 2017 Nov 23;19(6). pii: 17l02106. doi: 10.4088/PCC.17l02106. No abstract available.

7.

Change and dispersion of QT interval during treatment with quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: results from the TEA trial.

Jensen KG, Gärtner S, Correll CU, Rudå D, Klauber DG, Stentebjerg-Olesen M, Fagerlund B, Jepsen JR, Fink-Jensen A, Juul K, Pagsberg AK.

Psychopharmacology (Berl). 2018 Mar;235(3):681-693. doi: 10.1007/s00213-017-4784-5. Epub 2017 Nov 29.

PMID:
29185022
8.

A molecular pathway analysis informs the genetic risk for arrhythmias during antipsychotic treatment.

Drago A, Kure Fischer E.

Int Clin Psychopharmacol. 2018 Jan;33(1):1-14. doi: 10.1097/YIC.0000000000000198.

PMID:
29064910
9.

Prevalence of QT interval prolonging drug-drug interactions (QT-DDIs) in psychiatry wards of tertiary care hospitals in Pakistan: a multicenter cross-sectional study.

Khan Q, Ismail M, Haider I, Khan F.

Int J Clin Pharm. 2017 Dec;39(6):1256-1264. doi: 10.1007/s11096-017-0532-5. Epub 2017 Sep 12.

PMID:
28895028
10.

BPC 157 counteracts QTc prolongation induced by haloperidol, fluphenazine, clozapine, olanzapine, quetiapine, sulpiride, and metoclopramide in rats.

Strinic D, Belosic Halle Z, Luetic K, Nedic A, Petrovic I, Sucic M, Zivanovic Posilovic G, Balenovic D, Strbe S, Udovicic M, Drmic D, Stupnisek M, Lovric Bencic M, Seiwerth S, Sikiric P.

Life Sci. 2017 Oct 1;186:66-79. doi: 10.1016/j.lfs.2017.08.006. Epub 2017 Aug 7.

PMID:
28797793
11.

First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update [Internet].

Pillay J, Boylan K, Carrey N, Newton A, Vandermeer B, Nuspl M, MacGregor T, Jafri SHA, Featherstone R, Hartling L.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2017 Mar.

12.

Evaluation of the Effects of Quetiapine on QTc Prolongation in Critically Ill Patients.

Dube KM, DeGrado J, Hohlfelder B, Szumita PM.

J Pharm Pract. 2018 Jun;31(3):292-297. doi: 10.1177/0897190017711875. Epub 2017 Jun 6.

PMID:
28583014
13.

[Drug-drug interactions with risk of QT-prolongation. A epidemiological study in Belgian community pharmacies].

Vandael E, De WuLf I, Foulon V.

J Pharm Belg. 2016 Dec;(4):14-23. French.

PMID:
30281244
14.

Case Report and Review of the Literature: Cardiomyopathy in a Young Woman on High-Dose Quetiapine.

Smolders DME, Smolders WAP.

Cardiovasc Toxicol. 2017 Oct;17(4):478-481. doi: 10.1007/s12012-016-9390-y. Review.

PMID:
27804065
15.

A dual strategy to improve psychotic patients' compliance using sustained release quetiapine oral disintegrating tablets.

Refaat A, Sokar M, Ismail F, Boraei N.

Acta Pharm. 2016 Dec 1;66(4):515-532. doi: 10.1515/acph-2016-0041.

PMID:
27749256
16.

Coma After Quetiapine Fumarate Intentional Overdose in a 71-year-old Man: A Case Report.

Gibiino S, Trappoli A, Balzarro B, Atti AR, De Ronchi D.

Drug Saf Case Rep. 2015 Dec;2(1):3.

17.

Adverse events in children and adolescents treated with quetiapine: an analysis of adverse drug reaction reports from the Danish Medicines Agency database.

Jakobsen KD, Wallach-Kildemoes H, Bruhn CH, Hashemi N, Pagsberg AK, Fink-Jensen A, Nielsen J.

Int Clin Psychopharmacol. 2017 Mar;32(2):103-106. doi: 10.1097/YIC.0000000000000148.

PMID:
27685179
18.

A dose-dependent relationship between quetiapine and QTc interval.

Melada A, Krčmar T, Vidović A.

Int J Cardiol. 2016 Nov 1;222:893-894. doi: 10.1016/j.ijcard.2016.08.037. Epub 2016 Aug 5. No abstract available.

PMID:
27522397
19.

Severe proarrhythmic potential of risperidone compared to quetiapine in an experimental whole-heart model of proarrhythmia.

Frommeyer G, von der Ahe H, Brücher B, Dechering DG, Lange PS, Reinke F, Wasmer K, Köbe J, Pott C, Mönnig G, Eckardt L.

Naunyn Schmiedebergs Arch Pharmacol. 2016 Oct;389(10):1073-80. doi: 10.1007/s00210-016-1274-y. Epub 2016 Jul 12.

PMID:
27405774
20.

Drug-Induced Torsades de Pointes and Genetic Screening--Reply.

Gupta A, Pandey A.

JAMA Intern Med. 2016 Apr;176(4):561. doi: 10.1001/jamainternmed.2016.0076. No abstract available.

PMID:
27043107

Supplemental Content

Loading ...
Support Center